Cytokinetics annual debt-to-equity ratio
2014
2015
2016
2017
2018
2020
2021
Cytokinetics Debt-to-Equity Ratio Growth & History (CYTK)
Cytokinetics's debt-to-equity ratio was 0.72 for fiscal 2021.
View full Cytokinetics company overviewCytokinetics annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | 0.72 | 0.28 | +65.31% |
| 2020 | 2020-12-31 | 0.44 | — | — |
| 2018 | 2018-12-31 | 1.64 | 1.35 | +465.31% |
| 2017 | 2017-12-31 | 0.29 | −0.03 | −8.64% |
| 2016 | 2016-12-31 | 0.32 | 0.10 | +48.37% |
| 2015 | 2015-12-31 | 0.21 | 0.21 | — |
| 2014 | 2014-12-31 | 0.00 | — | — |
Cytokinetics quarterly debt-to-equity ratio
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q2.24
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2024 | 2024-06-30 | 2.21 | — | — |
| Q2 2022 | 2022-06-30 | 1.72 | −7.66 | −81.65% |
| Q1 2022 | 2022-03-31 | 1.63 | −0.39 | −19.34% |
| Q4 2021 | 2021-12-31 | 0.72 | 0.28 | +65.31% |
| Q3 2021 | 2021-09-30 | 0.67 | 0.33 | +99.12% |
| Q2 2021 | 2021-06-30 | 9.38 | — | — |
| Q1 2021 | 2021-03-31 | 2.03 | — | — |
| Q4 2020 | 2020-12-31 | 0.44 | — | — |
| Q3 2020 | 2020-09-30 | 0.34 | — | — |
| Q1 2019 | 2019-03-31 | 15.53 | 15.21 | +4740.42% |
| Q4 2018 | 2018-12-31 | 1.64 | 1.35 | +465.31% |
| Q3 2018 | 2018-09-30 | 0.80 | 0.60 | +290.55% |
| Q2 2018 | 2018-06-30 | 0.43 | 0.26 | +149.84% |
| Q1 2018 | 2018-03-31 | 0.32 | 0.01 | +1.94% |
| Q4 2017 | 2017-12-31 | 0.29 | −0.03 | −8.64% |
| Q3 2017 | 2017-09-30 | 0.21 | −0.14 | −41.30% |
| Q2 2017 | 2017-06-30 | 0.17 | −0.43 | −71.62% |
| Q1 2017 | 2017-03-31 | 0.31 | −0.19 | −38.15% |
| Q4 2016 | 2016-12-31 | 0.32 | 0.10 | +48.37% |
| Q3 2016 | 2016-09-30 | 0.35 | 0.35 | — |
| Q2 2016 | 2016-06-30 | 0.61 | 0.61 | — |
| Q1 2016 | 2016-03-31 | 0.51 | 0.51 | — |
| Q4 2015 | 2015-12-31 | 0.21 | 0.21 | — |
| Q3 2015 | 2015-09-30 | 0.00 | — | — |
| Q2 2015 | 2015-06-30 | 0.00 | — | — |
| Q1 2015 | 2015-03-31 | 0.00 | — | — |
| Q4 2014 | 2014-12-31 | 0.00 | — | — |
Cytokinetics debt-to-equity ratio trends
Over the last five fiscal years, Cytokinetics's debt-to-equity ratio increased from 0.32 to 0.72, a change of 0.40. The latest reported quarter, Q2 2024, shows 2.21.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytokinetics source filings ↗